GlassScriptPhysician profile
Rajesh Bazaz
NPI 1457364366
$7,082.16
in general payments reported to CMS, 2019-2025
10 companies · $1,074 in 2025
The $1,074 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $342 · 2021: $1,722 · 2022: $1,800 · 2023: $675 · 2024: $661 · 2025: $1,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,014.01 | 2019-2025 | Triathlon, Mako, Insignia |
| Gemini Mountain Medical, LLC | $2,444.95 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $230.86 | 2019-2024 | Tapestry |
| Pacira Therapeutics, INC. | $148.03 | 2019 | |
| Spr Therapeutics, INC | $98.79 | 2021 | |
| Depuy Synthes Sales INC. | $62.81 | 2024-2025 | Rigidloop, Intrafix, Gryphon Orthocord |
| Bioventus LLC | $33.72 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Pacira Pharmaceuticals Incorporated | $21.59 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.62 | 2019 | |
| Pfizer INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Bazaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.